AUC	Area Under the Curve
BCR	B-cell receptor
CNV	Copy Number Variant
CT	Computed Tomography
CTLA-4	Cytotoxic T Lymphocyte–Associated protein 4
CR	Complete Response
FDA	Food and Drug Administration
FDR	False Discovery rate
HR	Hazard Ratio
ICI	Immune Checkpoint Inhibitor
IQR	Interquartile Range
LAG-3	Lymphocyte-Activation Gene 3
LRT	Likelihood Ratio Test
MSI	Microsatellite Instability
MSS	Microsatellite Stable
NS	Not Significant
NSCL	Non-Small-Cell Lung cancer
NR	Not Reached
PD	Progressive Disease
PD1	Programmed cell Death protein-1
PD-L1	Programmed Death-Ligand 1
PFS	Progression-Free Survival
PR	Partial Response
PS	Performance Status
SD	Stable Disease
SNV	Single-Nucleotide Variants
TMB	Tumor Mutational Burden
TCR	T-cell Receptor
WHO	World Health Organization
WT	Wild-Type